Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ali Arar"'
Autor:
Sabine Kayser, Richard F. Schlenk, Delphine Lebon, Martin Carre, Katharina S. Götze, Friedrich Stölzel, Ana Berceanu, Kerstin Schäfer-Eckart, Pierre Peterlin, Yosr Hicheri, Ramy Rahme, Emmanuel Raffoux, Fatiha Chermat, Stefan W. Krause, Walter E. Aulitzky, Sophie Rigaudeau, Richard Noppeney, Celine Berthon, Martin Görner, Edgar Jost, Philippe Carassou, Ulrich Keller, Corentin Orvain, Thorsten Braun, Colombe Saillard, Ali Arar, Volker Kunzmann, Mathieu Wemeau, Maike de Wit, Dirk Niemann, Caroline Bonmati, Carsten Schwänen, Julie Abraham, Ahmad Aljijakli, Stephanie Haiat, Alwin Krämer, Albrecht Reichle, Martina Gnadler, Christophe Willekens, Karsten Spiekermann, Wolfgang Hiddemann, Carsten Müller-Tidow, Christian Thiede, Christoph Röllig, Hubert Serve, Martin Bornhäuser, Claudia D. Baldus, Eva Lengfelder, Pierre Fenaux, Uwe Platzbecker, Lionel Adès
Publikováno v:
Haematologica, Vol 106, Iss 12 (2021)
The aim of this study was to characterize a large series of 154 patients with acute promyelocytic leukemia (median age, 53 years; range, 18-90 years) and evaluate real-life outcome after up-front treatment with arsenic trioxide and all-trans retinoic
Externí odkaz:
https://doaj.org/article/d1110d66d5bd4ca48add2308757b49eb
Autor:
Florence Abdallah, Elodie Henriet, Amandine Suet, Ali Arar, Rudy Clemençon, Jean-Marc Malinge, Gaël Lecellier, Patrick Baril, Chantal Pichon
Publikováno v:
Cells, Vol 10, Iss 10, p 2547 (2021)
Psoriasis is a chronic inflammatory skin disease that is mediated by complex crosstalk between immune cells and keratinocytes (KCs). Emerging studies have showed a specific psoriatic microRNAs signature, in which miR-21 is one of the most upregulated
Externí odkaz:
https://doaj.org/article/31402c5e25124348af629a1fc76c61d3
Publikováno v:
Indian Journal of Public Health, Vol 63, Iss 4, Pp 330-333 (2019)
Background: Overweight and obesity are important modifiable risk factors for various noncommunicable diseases. The link between obesity, poor health outcomes, and all-cause mortality is well established. Overweight and obesity during childhood increa
Externí odkaz:
https://doaj.org/article/971d353f91f442b8a233f325ef8ee47d
Publikováno v:
Indian Journal of Public Health, Vol 63, Iss 4, Pp 330-333 (2019)
Background: Overweight and obesity are important modifiable risk factors for various noncommunicable diseases. The link between obesity, poor health outcomes, and all-cause mortality is well established. Overweight and obesity during childhood increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b81d0b8fdb4bca8b736ded7855ad24a7
https://pubmed.ncbi.nlm.nih.gov/32189653
https://pubmed.ncbi.nlm.nih.gov/32189653
Autor:
Katharina Götze, Jesús María Hernández Rivas, Guillermo Sanz, Teresa Bernal, Uwe Platzbecker, Blanca Xicoy, Ali Arar, Sylvain Thepot, Bohrane Slama, Consuelo del Cañizo, Maria Luz Amigo, Pierre Fenaux, Stefan Wickenhauser, Aristoteles Giagounidis, Agnès Guerci-Bresler, Joan Bargay, Raquel de Paz, Jose Angel Hernandez-Rivas, Félix López Cadenas, Eva Lumbreras, Benet Nomdedeu, Beatriz Arrizabalaga, Rosa Coll, María Díez-Campelo, Joaquín Sánchez
Publikováno v:
Blood. 136:28-29
Background: Most IPSS low and int1 (lower) risk MDS patients with isolated del(5q) develop RBC TD or need treatment for symptomatic anemia early after diagnosis (median time to transfusion/treatment of 20 months, López Cadenas et al abstract 3180 AS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a7b0f0891d6b52ff10ce25c841d134
https://doi.org/10.1182/blood-2020-140339
https://doi.org/10.1182/blood-2020-140339
Autor:
Teresa Bernal, Joan Bargay, Raquel de Paz, Jose Angel Hernandez-Rivas, Sylvain Thepot, Joaquin Sanchez-Garcia, Borhane Slama, Rosa Coll, Consuelo del Cañizo, Pierre Fenaux, Blanca Xicoy, María Díez-Campelo, Beatriz Arrizabalaga, Ali Arar, Eva Lumbreras, Eric Jourdan, Katharina Götze, Benet Nomdedeu, Félix López Cadenas, Maria Luz Amigo, Agnès Guerci, Guillermo Sanz, Aristoteles Giagounidis, Jesús María Hernández-Rivas, Uwe Platzbecker
Publikováno v:
Blood. 132:468-468
Background: Lenalidomide (LEN) is a reference treatment in IPSS low and in1 (lower) risk MDS patients with isolated de(5q) (MDS-del(5q)) and RBC - TD. Most low risk MDS-del(5q) patients with anemia and independent of transfusions develop TD or need o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed58e69fc53f8e9f92fa6582477c5e36
https://doi.org/10.1182/blood-2018-99-119430
https://doi.org/10.1182/blood-2018-99-119430